Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis.
Liu H, Yang CC, Ma YL, Yang YF, Yan LJ, Ding ZN, Xue JS, Yang LS, Yan YC, Dong ZR, Wang DX, Chen ZQ, Hong JG, Li T.
Liu H, et al. Among authors: yang ls, yang yf, yang cc.
Immunotherapy. 2023 Jun;15(9):669-678. doi: 10.2217/imt-2022-0114. Epub 2023 May 4.
Immunotherapy. 2023.
PMID: 37140011
Review.